Investors and Media
Stock Information
Price: $2.55   Change: + 0.08
Oct 21, 2014 4:00 PM ET
Investor Relations
Stock price graph

ZIOPHARM Oncology, Inc. is a biopharmaceutical company focused on the development and commercialization of new cancer therapies.

View all »   RSSRecent Releases

Aug 7, 2014
ZIOPHARM Reports Second-Quarter 2014 Financial Results and Reviews Recent Activities

Jul 31, 2014
ZIOPHARM Oncology and Solasia Pharma Announce Global License and Collaboration Agreement for Darinaparsin

Jun 25, 2014 at 10:00 AM ET
JMP Securities Healthcare Conference

Mar 28, 2014 at 3:00 PM ET
21st Annual Future Leaders in the Biotech Industry Conference